DIM.PA
Sartorius Stedim Biotech S.A.
ParisEUREQUITY
DELAYED
Last price
192.50
▼ 2.50 (1.28%)
MARKET · —
Price
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
194.50
Prev close
195.00
Day high
195.50
Day low
190.70
Volume
77.27K
Market cap
—
P/E (TTM)
—
52W range
150.00 – 224.00
Trailing performance
Returnvs SPY
1W
+4.31%
+5.7%
1M
+17.99%
+14.3%
3M
+12.70%
+9.6%
6M
+9.51%
-1.6%
YTD
-7.86%
-20.1%
1Y
+10.41%
-9.6%
3Y
-26.40%
-100.6%
5Y
-62.80%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Free account
3 more panels on DIM.PA open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $2.97B | $2.78B | $2.78B | $3.49B | +6.7% |
| Operating revenue | $2.97B | $2.78B | $2.78B | $3.49B | +6.7% |
| Cost of revenue | $1.62B | $1.57B | $1.54B | $1.68B | +3.1% |
| Gross profit | $1.35B | $1.21B | $1.23B | $1.82B | +11.5% |
| Research & development | $133.10M | $144.10M | $129.50M | $132.40M | -7.6% |
| Selling, general & admin | $661.30M | $648.50M | $616.00M | $611.90M | +2.0% |
| Total operating expense | $805.90M | $809.10M | $762.80M | $762.40M | -0.4% |
| Operating income | $539.40M | $397.60M | $471.20M | $1.05B | +35.7% |
| Net interest income | -$140.70M | -$140.00M | -$115.80M | -$9.70M | -0.5% |
| Pre-tax income | $373.20M | $219.20M | $401.90M | $1.13B | +70.3% |
| Tax provision | $107.30M | $40.70M | $89.20M | $250.50M | +163.6% |
| Net income | $265.60M | $175.10M | $310.30M | $876.10M | +51.7% |
| Net income to common | $265.60M | $175.10M | $310.30M | $876.10M | +51.7% |
| Basic EPS | 2.73 | 1.81 | 3.37 | 9.51 | +50.8% |
| Diluted EPS | 2.73 | 1.81 | 3.37 | 9.51 | +50.8% |
| EBIT | $512.70M | $368.80M | $518.90M | $1.15B | +39.0% |
| EBITDA | $830.80M | $670.50M | $755.70M | $1.33B | +23.9% |
| Basic shares | 97.30M | 96.74M | 92.16M | 92.16M | +0.6% |
| Diluted shares | 97.30M | 96.74M | 92.16M | 92.16M | +0.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $426.10M | $678.90M | $116.60M | $107.10M | -37.2% |
| Cash & short-term investments | $434.20M | $688.80M | $126.10M | $107.10M | -37.0% |
| Accounts receivable | $179.80M | $248.50M | $277.50M | $391.00M | -27.6% |
| Inventory | $690.90M | $684.90M | $882.40M | $1.02B | +0.9% |
| Total current assets | $1.44B | $1.74B | $1.42B | $1.67B | -17.2% |
| Property, plant & equipment | $2.02B | $1.89B | $1.63B | $1.29B | +7.4% |
| Goodwill & intangibles | $4.42B | $4.54B | $4.58B | $2.01B | -2.6% |
| Total assets | $7.98B | $8.26B | $7.73B | $5.07B | -3.3% |
| Total current liabilities | $1.41B | $938.80M | $937.30M | $1.04B | +50.4% |
| Current debt | $557.30M | $39.60M | $57.70M | $4.40M | +1,307.3% |
| Long-term debt | $1.87B | $2.68B | $3.51B | $1.02B | -30.4% |
| Total debt | $2.60B | $2.87B | $3.68B | $1.14B | -9.4% |
| Total liabilities | $3.86B | $4.23B | $5.06B | $2.55B | -8.9% |
| Retained earnings | $2.65B | $2.54B | $2.39B | $2.20B | +4.1% |
| Shareholder equity | $4.09B | $3.99B | $2.64B | $2.45B | +2.6% |
| Working capital | $29.10M | $802.20M | $477.80M | $635.30M | -96.4% |
| Net tangible assets | -$329.90M | -$552.90M | -$1.94B | $436.00M | +40.3% |
| Shares issued | 97.33M | 97.33M | 92.18M | 92.18M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $373.20M | $219.20M | $401.90M | $1.13B | +70.3% |
| Depreciation & amortisation | $318.10M | $301.70M | $236.80M | $181.70M | +5.4% |
| Change in working capital | -$25.40M | $251.00M | $190.70M | -$351.30M | -110.1% |
| Operating cash flow | $692.20M | $815.10M | $746.40M | $612.30M | -15.1% |
| Capital expenditure | -$393.20M | -$339.80M | -$473.60M | -$430.60M | -15.7% |
| Investing cash flow | -$397.70M | -$340.00M | -$2.72B | -$957.50M | -17.0% |
| Share buybacks | — | -$1.90M | — | — | — |
| Dividends paid | -$67.10M | -$67.10M | -$132.70M | -$116.10M | 0.0% |
| Financing cash flow | -$542.80M | $84.90M | $1.99B | $220.70M | -739.3% |
| Free cash flow | $299.00M | $475.30M | $272.80M | $181.70M | -37.1% |
| End cash position | $426.10M | $678.90M | $116.60M | $107.10M | -37.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $765.70M | $761.50M | $772.20M | $745.00M | $744.60M | +0.6% |
| Operating revenue | $765.70M | $761.50M | $772.20M | $745.00M | $744.60M | +0.6% |
| Cost of revenue | $406.90M | $416.10M | $455.30M | $400.30M | $388.30M | -2.2% |
| Gross profit | $358.80M | $345.40M | $316.90M | $344.70M | $356.30M | +3.9% |
| Research & development | $35.30M | $38.40M | $31.70M | $32.10M | $39.20M | -8.1% |
| Selling, general & admin | $163.30M | $163.40M | $170.20M | $167.00M | $166.50M | -0.1% |
| Total operating expense | $204.80M | $196.10M | $182.50M | $215.70M | $215.00M | +4.4% |
| Operating income | $154.00M | $149.30M | $134.40M | $129.00M | $141.30M | +3.1% |
| Net interest income | -$27.30M | -$30.10M | -$31.10M | -$36.30M | -$25.80M | +9.3% |
| Pre-tax income | $126.70M | $119.10M | $77.80M | $92.60M | $115.40M | +6.4% |
| Tax provision | $32.90M | $31.00M | $30.50M | $24.00M | $30.00M | +6.1% |
| Net income | $93.00M | $88.10M | $47.30M | $68.50M | $85.60M | +5.6% |
| Net income to common | $93.00M | $88.10M | $47.30M | $68.50M | $85.60M | +5.6% |
| Basic EPS | 0.96 | 0.91 | — | 0.70 | 0.88 | +5.5% |
| Diluted EPS | 0.96 | 0.91 | — | 0.70 | 0.88 | +5.5% |
| EBIT | $160.90M | $165.60M | $71.60M | $128.90M | $178.70M | -2.8% |
| EBITDA | $240.30M | $246.70M | $155.50M | $206.80M | $256.10M | -2.6% |
| Basic shares | 96.88M | 96.81M | — | 97.86M | 97.27M | +0.1% |
| Diluted shares | 96.88M | 96.81M | — | 97.86M | 97.27M | +0.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $203.90M | $521.20M | $426.10M | $699.30M | $707.60M | -60.9% |
| Cash & short-term investments | $203.90M | $547.40M | $434.20M | $745.10M | $727.00M | -62.8% |
| Accounts receivable | $273.20M | $260.40M | $179.80M | $263.80M | $267.00M | +4.9% |
| Inventory | $714.30M | $714.70M | $690.90M | $693.90M | $683.50M | -0.1% |
| Total current assets | $1.35B | $1.65B | $1.44B | $1.81B | $1.78B | -18.1% |
| Property, plant & equipment | $2.06B | $2.03B | $2.02B | $1.95B | $1.93B | +1.5% |
| Goodwill & intangibles | $4.39B | $4.40B | $4.42B | $4.46B | $4.50B | -0.2% |
| Total assets | $7.92B | $8.19B | $7.98B | $8.31B | $8.30B | -3.3% |
| Total current liabilities | $1.17B | $1.61B | $1.41B | $946.10M | $964.70M | -27.5% |
| Current debt | $289.90M | $581.70M | $557.30M | $110.70M | $69.00M | -50.2% |
| Long-term debt | $1.94B | $1.86B | $1.87B | $2.68B | $2.68B | +4.4% |
| Total debt | $2.40B | $2.61B | $2.60B | $2.97B | $2.93B | -8.1% |
| Total liabilities | $3.67B | $4.05B | $3.86B | $4.27B | $4.30B | -9.3% |
| Retained earnings | $2.79B | $2.66B | $2.65B | $2.56B | $2.53B | +4.8% |
| Shareholder equity | $4.24B | $4.11B | $4.09B | $4.00B | $3.97B | +3.1% |
| Working capital | $186.20M | $41.50M | $29.10M | $861.00M | $815.30M | +348.7% |
| Net tangible assets | -$157.20M | -$294.40M | -$329.90M | -$453.60M | -$528.50M | +46.6% |
| Shares issued | 97.33M | 97.33M | 97.33M | 97.33M | 97.33M | 0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $126.70M | $119.10M | $77.80M | — | $92.60M | $115.40M | +6.4% |
| Depreciation & amortisation | $79.40M | $81.10M | $83.90M | — | $77.90M | $77.40M | -2.1% |
| Change in working capital | -$41.90M | -$17.10M | $59.40M | — | -$56.90M | -$34.70M | -145.0% |
| Operating cash flow | $147.90M | $193.30M | $246.50M | — | $124.90M | $119.80M | -23.5% |
| Capital expenditure | -$72.80M | -$69.60M | -$117.10M | — | -$75.90M | -$65.30M | -4.6% |
| Investing cash flow | -$72.80M | -$69.60M | -$118.80M | — | -$76.90M | -$65.30M | -4.6% |
| Share buybacks | $2.40M | -$2.90M | — | — | $1.10M | -$2.00M | +182.8% |
| Dividends paid | — | — | $0 | — | — | — | — |
| Financing cash flow | -$394.70M | -$29.20M | $900.00K | -$464.90M | -$53.20M | — | -1,251.7% |
| Free cash flow | $75.10M | $123.70M | $129.40M | — | $49.00M | $54.50M | -39.3% |
| End cash position | $203.90M | $521.20M | $426.10M | — | $699.30M | $707.60M | -60.9% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
184.23
+4.49% from price
SMA 20
177.69
+8.90% from price
SMA 50
176.92
+9.37% from price
SMA 100
173.67
+10.84% from price
SMA 200
182.38
+6.10% from price
EMA 12
183.77
+4.75% from price
EMA 26
180.02
+6.93% from price
EMA 50
177.70
+8.33% from price
RSI (14)
65.2
Neutral
MACD (12,26,9)
3.75
Hist 1.86
ATR (14)
5.61
2.90% of price
Realised vol 30D
46.8%
Annualised
Bollinger upper
193.74
20, 2σ
Bollinger lower
161.64
20, 2σ
50 / 200 cross
Death
176.92 vs 182.38
Trend bias
Above 200
+6.10%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.30
Less volatile than market
Correlation to SPY
0.10
Largely independent
Realised vol 30D
46.8%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-32.1%
Peak to trough
Max drawdown 5Y
-73.5%
Peak to trough
ATR 14
5.61
2.90% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Solana Is Beating Ethereum in Tokenized Assets. That Might Not Make It the Better Buy.
Motley Fool · 15m ago
Zcash Hits Eight-Year High After Grayscale Advances U.S. ETF Push
CryptoProwl · 15m ago
Another travel company shuts down and cancels all trips, refunds available
TheStreet · 16m ago
How Your Social Security Benefit Is Actually Calculated
Motley Fool · 16m ago
Pegula dethrones Swiatek to reach Cincinnati final
AFP · 17m ago
Canada to impose retaliatory tariffs on US steel, electronics, other products, Carney says
Reuters · 19m ago
Quantum Computing vs. Red Cat: Which High-Growth Innovation Stock Is a Better Buy in 2026?
Motley Fool · 20m ago
IPO Fever Heats Up for OpenAI and Anthropic
Motley Fool · 23m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.